{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7492,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a Gantt-style visualization to represent drug development stages.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/5",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-5",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "context",
      "function": "establish_context",
      "notes": "The slide uses a four-column layout to structure the disease overview.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/6",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-6",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "The slide uses a map to show regional prevalence and a nested circle diagram to show the funnel from total infected to treated patients.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/7",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-7",
      "loopMatches": [
        {
          "to": 7,
          "from": 7,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "cb04ba74-1ad4-41a8-8ee8-d093322ec7b3",
          "evidence": "The document highlights the unmet medical need.",
          "position": 0,
          "objective": "What is the cost of not addressing HBV?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 7,
          "from": 7,
          "beatId": "3adfa18e-bbfe-4577-8cc3-d51ef78ca459",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "The document identifies HBV as a significant unmet medical need.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 7,
          "from": 7,
          "beatId": "48052fad-de34-4402-80d4-848fa58261ba",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The document highlights the limitations of current treatments.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a process-oriented flow diagram to explain the therapeutic strategy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/8",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-8",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 26,
          "from": 8,
          "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/9",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-9",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 26,
          "from": 8,
          "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide highlights the mechanism of action and key benefits of the drug candidate.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/10",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-10",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 26,
          "from": 8,
          "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "traction",
      "function": "analyze_data",
      "notes": "Data presented at EASL 2022, AASLD 2022, GHS 2023.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/11",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-11",
      "loopMatches": [
        {
          "to": 18,
          "from": 11,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "9268b1b4-494b-44ee-8454-6a997fc0aa8b",
          "evidence": "The document presents clinical trial results and data.",
          "position": 1,
          "objective": "Can Imdusiran RNAi therapeutic and AB-101 oral PD-L1 inhibitor provide a quick win or a big bet for investors?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 26,
          "from": 8,
          "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        },
        {
          "to": 18,
          "from": 11,
          "beatId": "bb704643-20a7-459a-9df1-5b5cea9225d9",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "The document presents clinical trial results and data.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Data presented at EASL 2022. Shows dual-axis line charts for viral load/ALT and bar charts for T-cell frequency.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/12",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-12",
      "loopMatches": [
        {
          "to": 18,
          "from": 11,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "9268b1b4-494b-44ee-8454-6a997fc0aa8b",
          "evidence": "The document presents clinical trial results and data.",
          "position": 1,
          "objective": "Can Imdusiran RNAi therapeutic and AB-101 oral PD-L1 inhibitor provide a quick win or a big bet for investors?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 26,
          "from": 8,
          "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        },
        {
          "to": 18,
          "from": 11,
          "beatId": "bb704643-20a7-459a-9df1-5b5cea9225d9",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "The document presents clinical trial results and data.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/13",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-13",
      "loopMatches": [
        {
          "to": 18,
          "from": 11,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "9268b1b4-494b-44ee-8454-6a997fc0aa8b",
          "evidence": "The document presents clinical trial results and data.",
          "position": 1,
          "objective": "Can Imdusiran RNAi therapeutic and AB-101 oral PD-L1 inhibitor provide a quick win or a big bet for investors?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 26,
          "from": 8,
          "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        },
        {
          "to": 18,
          "from": 11,
          "beatId": "bb704643-20a7-459a-9df1-5b5cea9225d9",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "The document presents clinical trial results and data.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "The slide outlines a clinical trial protocol with specific patient counts (n=12, n=8) and timeline milestones (weeks 1, 24, 28, 40, 52).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/14",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-14",
      "loopMatches": [
        {
          "to": 18,
          "from": 11,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "9268b1b4-494b-44ee-8454-6a997fc0aa8b",
          "evidence": "The document presents clinical trial results and data.",
          "position": 1,
          "objective": "Can Imdusiran RNAi therapeutic and AB-101 oral PD-L1 inhibitor provide a quick win or a big bet for investors?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 26,
          "from": 8,
          "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        },
        {
          "to": 18,
          "from": 11,
          "beatId": "bb704643-20a7-459a-9df1-5b5cea9225d9",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "The document presents clinical trial results and data.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "traction",
      "function": "analyze_data",
      "notes": "Data presented at EASL 2023. Includes both a summary table of mean changes and individual patient trajectory charts.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/15",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-15",
      "loopMatches": [
        {
          "to": 18,
          "from": 11,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "9268b1b4-494b-44ee-8454-6a997fc0aa8b",
          "evidence": "The document presents clinical trial results and data.",
          "position": 1,
          "objective": "Can Imdusiran RNAi therapeutic and AB-101 oral PD-L1 inhibitor provide a quick win or a big bet for investors?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 26,
          "from": 8,
          "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        },
        {
          "to": 18,
          "from": 11,
          "beatId": "bb704643-20a7-459a-9df1-5b5cea9225d9",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "The document presents clinical trial results and data.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "Shows two parallel study arms with randomization at week 24/26.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/16",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-16",
      "loopMatches": [
        {
          "to": 18,
          "from": 11,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "9268b1b4-494b-44ee-8454-6a997fc0aa8b",
          "evidence": "The document presents clinical trial results and data.",
          "position": 1,
          "objective": "Can Imdusiran RNAi therapeutic and AB-101 oral PD-L1 inhibitor provide a quick win or a big bet for investors?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 26,
          "from": 8,
          "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        },
        {
          "to": 18,
          "from": 11,
          "beatId": "bb704643-20a7-459a-9df1-5b5cea9225d9",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "The document presents clinical trial results and data.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data presented at AASLD 2023; includes both a summary table and a longitudinal line chart with error bars.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/17",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-17",
      "loopMatches": [
        {
          "to": 18,
          "from": 11,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "9268b1b4-494b-44ee-8454-6a997fc0aa8b",
          "evidence": "The document presents clinical trial results and data.",
          "position": 1,
          "objective": "Can Imdusiran RNAi therapeutic and AB-101 oral PD-L1 inhibitor provide a quick win or a big bet for investors?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 26,
          "from": 8,
          "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        },
        {
          "to": 18,
          "from": 11,
          "beatId": "bb704643-20a7-459a-9df1-5b5cea9225d9",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "The document presents clinical trial results and data.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Data presented at AASLD 2023. Shows ELISpot results for T cell responses and HBsAg levels.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/18",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-18",
      "loopMatches": [
        {
          "to": 18,
          "from": 11,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "9268b1b4-494b-44ee-8454-6a997fc0aa8b",
          "evidence": "The document presents clinical trial results and data.",
          "position": 1,
          "objective": "Can Imdusiran RNAi therapeutic and AB-101 oral PD-L1 inhibitor provide a quick win or a big bet for investors?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 26,
          "from": 8,
          "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        },
        {
          "to": 18,
          "from": 11,
          "beatId": "bb704643-20a7-459a-9df1-5b5cea9225d9",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "The document presents clinical trial results and data.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide details a specific licensing deal with Qilu Pharmaceutical, including financial terms and geographic scope.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/19",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 26,
          "from": 8,
          "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/20",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 26,
          "from": 8,
          "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a three-column layout to explain the scientific basis and product advantages.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/21",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 26,
          "from": 8,
          "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes both in vitro (IFN-y fold increase) and in vivo (MC38 tumor model) efficacy data.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/22",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 26,
          "from": 8,
          "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "The slide outlines a multi-part clinical trial structure with specific cohort sizes and dosing progression.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/23",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 26,
          "from": 8,
          "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "appendix",
      "function": "other",
      "notes": "Includes a footnote regarding the 3/21/2023 Court Scheduling Order.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/24",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 26,
          "from": 8,
          "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "timeline",
      "function": "plan_implementation",
      "notes": "The slide includes a financial disclaimer regarding cash balance and burn.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/25",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 26,
          "from": 8,
          "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        },
        {
          "to": 26,
          "from": 25,
          "beatId": "da1adf1d-15f4-4705-bfe7-3a2a4da5df9e",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines key milestones and a call to action.",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-906b-74a9-92f8-5c2872231d60",
      "docSlug": "a8776e7183e96a109d1a49143fc2ff88",
      "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides",
      "authorId": "arbutus-biopharma",
      "authorName": "Arbutus Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "closing_ask",
      "function": "state_next_steps",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/26",
      "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60",
      "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 26,
          "from": 8,
          "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        },
        {
          "to": 26,
          "from": 25,
          "beatId": "da1adf1d-15f4-4705-bfe7-3a2a4da5df9e",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines key milestones and a call to action.",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9103-7399-8bed-9b1b1a8b182a",
      "docSlug": "93c36ca1f8977b3a70b566ce0ab54138",
      "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides",
      "authorId": "argenx-se",
      "authorName": "argenx",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/smlp4Azd0Ahdg9W2wbvCnhJetplcWC2zXVpzsrlZMKo/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85M2MzNmNhMWY4OTc3YjNhNzBiNTY2Y2UwYWI1NDEzOC9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/1",
      "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a",
      "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 3,
          "from": 1,
          "beatId": "cd56e8ef-e634-4e44-acce-3a6024b15bf6",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Humble Origins",
          "beatSlug": "rags-to-riches-humble-origins",
          "evidence": "Introduction to argenx SE and its journey",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Setup",
          "parentBeatSlug": "setup"
        }
      ],
      "imagePathAlt": "https://imgproxy.kitesheet.com/2clKUcFxMrXoa78-DAEHgAawcL-1jTNAxV3ZOmYpEa8/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85M2MzNmNhMWY4OTc3YjNhNzBiNTY2Y2UwYWI1NDEzOC9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/ddq-h42um4yTZJRHJdpH22pNgogbxuA9jNIOIED65h8/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85M2MzNmNhMWY4OTc3YjNhNzBiNTY2Y2UwYWI1NDEzOC9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/XinXVMj_fmk7ej2zbBBYuuPS98YHqEBxTM9WtEruhVE/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85M2MzNmNhMWY4OTc3YjNhNzBiNTY2Y2UwYWI1NDEzOC9wMDAxLnBuZw"
    },
    {
      "docId": "019de076-9103-7399-8bed-9b1b1a8b182a",
      "docSlug": "93c36ca1f8977b3a70b566ce0ab54138",
      "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides",
      "authorId": "argenx-se",
      "authorName": "argenx",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/2",
      "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a",
      "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 3,
          "from": 1,
          "beatId": "cd56e8ef-e634-4e44-acce-3a6024b15bf6",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Humble Origins",
          "beatSlug": "rags-to-riches-humble-origins",
          "evidence": "Introduction to argenx SE and its journey",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Setup",
          "parentBeatSlug": "setup"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9103-7399-8bed-9b1b1a8b182a",
      "docSlug": "93c36ca1f8977b3a70b566ce0ab54138",
      "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides",
      "authorId": "argenx-se",
      "authorName": "argenx",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "key_messages",
      "function": "present_framework",
      "notes": "The infinity loop suggests a continuous, self-reinforcing process of innovation.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/3",
      "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a",
      "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 3,
          "from": 1,
          "beatId": "cd56e8ef-e634-4e44-acce-3a6024b15bf6",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Humble Origins",
          "beatSlug": "rags-to-riches-humble-origins",
          "evidence": "Introduction to argenx SE and its journey",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Setup",
          "parentBeatSlug": "setup"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9103-7399-8bed-9b1b1a8b182a",
      "docSlug": "93c36ca1f8977b3a70b566ce0ab54138",
      "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides",
      "authorId": "argenx-se",
      "authorName": "argenx",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "testimonial",
      "function": "illustrate_case",
      "notes": "The slide uses a large portrait of a patient to build emotional connection and credibility.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/4",
      "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a",
      "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 4,
          "beatId": "ad3dc0fe-411f-4efc-be3f-8dd150f1a6c0",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Early Struggles",
          "beatSlug": "rags-to-riches-early-struggles",
          "evidence": "Discussion of challenges and innovation horizons",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9103-7399-8bed-9b1b1a8b182a",
      "docSlug": "93c36ca1f8977b3a70b566ce0ab54138",
      "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides",
      "authorId": "argenx-se",
      "authorName": "argenx",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "roadmap",
      "function": "present_framework",
      "notes": "Uses a concentric circle/horizon layout to represent different stages of development and commercialization.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/5",
      "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a",
      "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-5",
      "loopMatches": [
        {
          "to": 14,
          "from": 5,
          "name": "Why Now",
          "slug": "15-why-now",
          "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
          "matchId": "f381209b-40fa-4c32-8920-66d6dea883b8",
          "evidence": "Discussion of innovation horizons and market opportunities",
          "position": 0,
          "objective": "Why now is the time for argenx SE's innovation",
          "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
          "confidence": 0.7,
          "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 4,
          "beatId": "ad3dc0fe-411f-4efc-be3f-8dd150f1a6c0",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Early Struggles",
          "beatSlug": "rags-to-riches-early-struggles",
          "evidence": "Discussion of challenges and innovation horizons",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9103-7399-8bed-9b1b1a8b182a",
      "docSlug": "93c36ca1f8977b3a70b566ce0ab54138",
      "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides",
      "authorId": "argenx-se",
      "authorName": "argenx",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a circular/concentric layout to represent the 'horizon' of opportunities, with the pipeline on the left and commercial/development milestones on the right.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/6",
      "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a",
      "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-6",
      "loopMatches": [
        {
          "to": 14,
          "from": 5,
          "name": "Why Now",
          "slug": "15-why-now",
          "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
          "matchId": "f381209b-40fa-4c32-8920-66d6dea883b8",
          "evidence": "Discussion of innovation horizons and market opportunities",
          "position": 0,
          "objective": "Why now is the time for argenx SE's innovation",
          "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
          "confidence": 0.7,
          "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 4,
          "beatId": "ad3dc0fe-411f-4efc-be3f-8dd150f1a6c0",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Early Struggles",
          "beatSlug": "rags-to-riches-early-struggles",
          "evidence": "Discussion of challenges and innovation horizons",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9103-7399-8bed-9b1b1a8b182a",
      "docSlug": "93c36ca1f8977b3a70b566ce0ab54138",
      "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides",
      "authorId": "argenx-se",
      "authorName": "argenx",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": "The slide uses an infinity-loop style diagram to connect three pillars of leadership.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/7",
      "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a",
      "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-7",
      "loopMatches": [
        {
          "to": 14,
          "from": 5,
          "name": "Why Now",
          "slug": "15-why-now",
          "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
          "matchId": "f381209b-40fa-4c32-8920-66d6dea883b8",
          "evidence": "Discussion of innovation horizons and market opportunities",
          "position": 0,
          "objective": "Why now is the time for argenx SE's innovation",
          "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
          "confidence": 0.7,
          "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 7,
          "beatId": "10300344-3ff1-4b97-95a5-8662d641a2aa",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Rising Success",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Highlighting commercial execution and market opportunities",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-9103-7399-8bed-9b1b1a8b182a",
      "docSlug": "93c36ca1f8977b3a70b566ce0ab54138",
      "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides",
      "authorId": "argenx-se",
      "authorName": "argenx",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": "The slide highlights clinical outcomes (QoL, MG-ADL scores), treatment protocols (steroid tapering), patient support (My VYVGART Path), and economic value (cost/benefit vs IVIg).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/8",
      "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a",
      "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-8",
      "loopMatches": [
        {
          "to": 14,
          "from": 5,
          "name": "Why Now",
          "slug": "15-why-now",
          "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
          "matchId": "f381209b-40fa-4c32-8920-66d6dea883b8",
          "evidence": "Discussion of innovation horizons and market opportunities",
          "position": 0,
          "objective": "Why now is the time for argenx SE's innovation",
          "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
          "confidence": 0.7,
          "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 7,
          "beatId": "10300344-3ff1-4b97-95a5-8662d641a2aa",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Rising Success",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Highlighting commercial execution and market opportunities",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}